Entamoeba histolytica, the causative agent for amoebiasis is a considerable burden to population in the developing countries where it accounts for over 50 million infections. The tools for detection of amoebiasis are inadequate and diagnosis relies on microscopy which means a significant percent of cases remain undiagnosed. Moreover, tests formats that can be rapidly applied in rural endemic areas are not available. In this study, a loop-mediated isothermal test (LAMP) based on 18S small subunit ribosomal RNA gene was designed with extra reaction accelerating primers (stem primers) and compared with the published LAMP and PCR tests in detection of E. histolytica DNA in clinical samples. The stem LAMP test indicated shorter time to results by an average 11 min and analytical sensitivity of 10−7 (~30 pg/ml) compared to the standard LAMP and PCR which showed sensitivities levels of 10−5 (~3 ng/ml) and 10−4 (~30 ng/ml) respectively using tenfold serial dilution of DNA. In the analysis of clinical specimens positive for Entamoeba spp. trophozoites and cysts using microscopy, the stem LAMP test detected E. histolytica DNA in 36/126, standard LAMP test 20/126 and PCR 17/126 cases respectively. There was 100% agreement in detection of the stem LAMP test product using fluorescence of SYTO-9 dye in real time machine, through addition of 1/10 dilution of SYBR® Green I and electrophoresis in 2% agarose gel stained with ethidium bromide. The stem LAMP test developed in this study indicates potential towards detection of E. histolytica.
3 May 2024 in Journal of Infection and Public Health
Background: COVID-19 epidemiology changed with the emergence of SARS-CoV-2 variants of concern (VOC). Pakistan administered mostly inactivated vaccines. We investigated the association between VOC and breakthrough infections in a mixed-vaccination-status population of Karachi. Methods: We investigated SARS-CoV-2 VOC tested in 392 respiratory specimens collected between May and December 2021. Data for age, sex, hospital admission, vaccinations, together with CT values of the diagnostic PCR test were analyzed. Results: The median age of COVID-19 cases tested was 40 (27-57) years and 43.4% were female. Delta variants were most common (56.4%) followed by Alpha (15.9%), Omicron (12.2%), Beta/Gamma (11.3%), and others (4.3%). Eighteen percent of cases were hospitalized whereby, predominant VOC were Beta/Gamma (40.8%), Alpha (35.2%) and Delta (22.5%). Overall, 55.4% of individuals were fully vaccinated, 7.4% were partially vaccinated and 37.2% were unvaccinated. Most (74.6%) inpatients were unvaccinated. Vaccines comprised inactivated (85.34%), single-shot vector (8.62%), two-shot vector (3.02%) and mRNA (3.02%) types. Omicron variants showed lower viral loads as compared to Alpha, Beta/Gamma, and Delta (p = 0.017). The risk of infection with Delta and Omicron variants was higher, 8 weeks after vaccination. The majority of those with breakthrough infections after receiving inactivated vaccines acquired COVID-19 within 4 months of vaccination. Conclusion: Our data highlights the shifting of VOC from Delta to Omicron during 2021 and that COVID-19 vaccinations reduced both hospitalizations and viral transmission. It informs on the increased risk of breakthrough infection within 8 weeks of vaccination, indicating the need for booster vaccinations. (c) 2024 Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY IGO license (http://creativecommons.org/licenses/by/3.0/igo/).
Background: About 1.6 million COVID-19 cases have been reported from Pakistan across 6 pandemic waves associated with different SARS-CoV-2 variants. Vaccinations were introduced in 2021 however there is paucity of information regarding the effect of vaccinations in the context of SARS-CoV-2 viral transmission. We investigated the association of vaccinations with circulating SARS-CoV-2 variants by studying the phylogenetic diversity of strains infecting vaccinated and unvaccinated cases in Pakistan. Methods We analyzed the diversity of SARS-CoV-2 strains in children (< 18 years) tested at Aga Khan University Hospital during the period. We downloaded SARS-CoV-2 genome data from GISAID for samples collected May 2021-October 2022. SARS-CoV-2 variants were analyzed as per age, sex and vaccination status. Phylogenetic diversity was determined using the Augur pipeline and visualized using the Auspice platform. Results Of the 569 samples analyzed, 54.1% samples were collected in 2021, 47.1% were from females, and 71% were from individuals aged below 18 years. Variants identified include Wildtype (3.87%), Alpha (2.11%), Beta (1.76%), Delta (45.17%), and Omicron (45.87%). The dominant variant in 2021 was Delta, mainly the B.1.167.2 lineage, while Omicron dominated in 2022 with BA.5.2 being the most common lineage. Overall, 29.3% of the cohort was vaccinated. Of note, there was no difference in preponderance of variants between vaccinated and unvaccinated groups. There was no difference in SARS-CoV-2 variant distribution among age groups. Genomic divergence between those < 18 years and >18 years was similar. Facility-based analysis on pediatrics aged < 18 years showed Delta and Omicron to have been dominant in 2021 and 2022 respectively. PCR-based comparison of viral load revealed a significant variability (p=0.0002) among the SARS-CoV-2 variants. Amongst children, Omicron had the highest viral load. Conclusions Our study reveals that SARS-CoV-2 infections were caused by similar strains in both vaccinated and unvaccinated cohorts, as well as between younger and older age groups. This provides important insights into a population where high rates of subclinical transmission were observed and explains the low rates of COVID-19 morbidity and mortality observed.
Background Pakistan experienced six COVID-19 waves with varying SARS-CoV-2 variants. Vaccination campaigns began in 2021, in an age-stratified manner starting with the older-aged individuals, yet the relationship between vaccination status and variant transmission remains unclear. We investigated SARS-CoV-2 phylogenetic diversity in relation to age and vaccination status, with a focus on children. Methods We analyzed 569 SARS-CoV-2 genome sequences collected across Pakistan from May 2021 to October 2022. Metadata including age, sex, and vaccination status were retrieved from GISAID. Additional data such as viral load was available for a set of 143 pediatric samples (< 18 years) sequenced at Aga Khan University Hospital (AKUH), Karachi, and was analyzed separately to gain further insights. Phylogenetic analyses were conducted using the Augur pipeline and visualized via Auspice. Viral loads were inferred from Ct values of SARS-CoV-2 PCR diagnostic assays. Results Among the 569 genomes, Delta (45.2%) dominated in 2021 and Omicron (45.9%) in 2022. Of these, 71% were from individuals <18 years; 29.3% were vaccinated. Variant distribution showed no significant difference between vaccinated and unvaccinated individuals (p=0.75), nor between age groups (<18 vs ≥18 years; p=0.60). Pediatric samples from AKUH Karachi mirrored national trends, with Delta predominating in 2021 and Omicron in 2022. Omicron variants were associated with higher viral loads (p<0.001). Conclusions SARS-CoV-2 variant distribution and genomic divergence were comparable across vaccination status and age groups. In a population with high subclinical transmission and delayed pediatric vaccination, our findings highlight the stability of variant spread irrespective of host immunity status, suggesting the role of widespread prior exposure in shaping transmission dynamics.
Background Pakistan experienced six COVID-19 waves with varying SARS-CoV-2 variants. Vaccination campaigns began in 2021, in an age-stratified manner starting with the older-aged individuals, yet the relationship between vaccination status and variant transmission remains unclear. We investigated SARS-CoV-2 phylogenetic diversity in relation to age and vaccination status, with a focus on children. Methods We analyzed 569 SARS-CoV-2 genome sequences collected across Pakistan from May 2021 to October 2022. Metadata including age, sex, and vaccination status were retrieved from GISAID. Additional data such as viral load was available for a set of 143 pediatric samples (< 18 years) sequenced at Aga Khan University Hospital (AKUH), Karachi, and was analyzed separately to gain further insights. Phylogenetic analyses were conducted using the Augur pipeline and visualized via Auspice. Viral loads were inferred from Ct values of SARS-CoV-2 PCR diagnostic assays. Results Among the 569 genomes, Delta (45.2%) dominated in 2021 and Omicron (45.9%) in 2022. Of these, 71% were from individuals <18 years; 29.3% were vaccinated. Variant distribution showed no significant difference between vaccinated and unvaccinated individuals (p=0.75), nor between age groups (<18 vs ≥18 years; p=0.60). Pediatric samples from AKUH Karachi mirrored national trends, with Delta predominating in 2021 and Omicron in 2022. Omicron variants were associated with higher viral loads (p<0.001). Conclusions SARS-CoV-2 variant distribution and genomic divergence were comparable across vaccination status and age groups. In a population with high subclinical transmission and delayed pediatric vaccination, our findings highlight the stability of variant spread irrespective of host immunity status, suggesting the role of widespread prior exposure in shaping transmission dynamics.